Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Anika Therapeutics reported $274.02M in Equity Capital and Reserves for its fiscal quarter ending in June of 2023.

Equity Capital And Reserves Change Date
Acorda Therapeutics USD 67.87M 9.09M Jun/2023
Agios Pharmaceuticals USD 886.84M 77.39M Sep/2023
Arrowhead Research USD 271.34M 93.49M Sep/2023
Enanta Pharmaceuticals USD 216.74M 21.08M Sep/2023
Halozyme Therapeutics USD 249.18M 98.15M Sep/2023
Heron Therapeutics USD -27786000 11.5M Sep/2023
Insmed USD -289357000 133.61M Sep/2023
Integra LifeSciences USD 1.58B 103.94M Sep/2023
Intrexon USD 147.68M 18.53M Sep/2023
Ligand Pharmaceuticals USD 665.4M 510K Sep/2023
Merit Medical Systems USD 1.23B 26.18M Sep/2023
Peregrine Pharmaceuticals USD 183.68M 6.92M Sep/2023
Rigel Pharmaceuticals USD -31834000 3.72M Sep/2023
Smith & Nephew USD 5.23B 26M Jun/2023
Stryker USD 17.9B 544M Sep/2023
Surmodics USD 119.91M 7.5M Sep/2023
Veracyte USD 1.05B 28.66M Sep/2023
Xencor USD 669.01M 9.87M Sep/2023
Zimmer Biomet Holdings USD 12.52B 146.5M Sep/2023